文献速递基础与转化研究新药、器械与细胞基因治疗研发

cGAS-STING介导的DNA感知维持CD8+ T细胞干性并促进抗肿瘤T细胞治疗

cGAS-STING-mediated DNA sensing maintains CD8+ T cell stemness and promotes antitumor T cell therapy.
PubMed 文献 · Sci Transl Med · 2020-01-01

该研究探讨T细胞内在cGAS-STING激活的作用,发现癌症患者外周血CD8+ T细胞中cGAS-STING级联表达显著受损。在小鼠过继转移CD8+ T细胞中,cGAS-STING级联对抗肿瘤免疫应答至关重要,其通过调控TCF1表达和自分泌I型干扰素信号抑制Akt活性来维持干细胞样CD8+ T细胞。STING激动剂增强患者来源的干性中央记忆CD8+ T细胞形成,并在异种移植模型中增强CAR-T细胞疗法的抗肿瘤反应。

要点

  • 癌症患者CD8+ T细胞中cGAS-STING级联表达显著受损。
  • T细胞内在cGAS-STING通过TCF1和I型干扰素-Akt轴维持干性。
  • STING激动剂可增强CAR-T抗肿瘤反应。

核心结论

  • T细胞内在cGAS-STING激活通过维持CD8+ T细胞干性促进抗肿瘤免疫,STING激动可改善T细胞疗法。

研究设计与样本

  • 研究检测癌症患者外周血CD8+ T细胞cGAS-STING表达,并在小鼠过继转移T细胞治疗模型中验证其功能。
  • 体外和体内刺激小鼠CD8+ T细胞,并利用癌症患者样本和异种移植模型评估STING激动对CAR-T的作用。

主要发现

  • 癌症患者外周血CD8+ T细胞cGAS-STING级联表达显著受损。
  • 小鼠过继转移CD8+ T细胞中cGAS-STING级联对抗肿瘤免疫应答必需。
  • 细胞自主cGAS和STING通过调控转录因子TCF1表达部分维持干细胞样CD8+ T细胞。
  • 自分泌cGAS-STING介导的I型干扰素信号主要通过抑制Akt活性增强干细胞样CD8+ T细胞分化程序。
  • 体外和体内刺激后小鼠CD8+ T细胞胞质中基因组DNA选择性富集。

临床怎么用

  • STING激动剂可增强癌症患者来源的干性中央记忆CD8+ T细胞形成。
  • STING激动在异种移植模型中增强CAR-T细胞疗法的抗肿瘤反应。
  • 利用cGAS-STING通路有望开发改进的T细胞疗法用于癌症免疫治疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Although cGAS-STING-mediated DNA sensing in tumor cells or phagocytes is central for launching antitumor immunity, the role of intrinsic cGAS-STING activation in T cells remains unknown. Here, we observed that peripheral blood CD8+ T cells from patients with cancer showed remarkably compromised expression of the cGAS-STING cascade. We demonstrated that the cGAS-STING cascade in adoptively transferred CD8+ T cells was essential for antitumor immune responses in the context of T cell therapy in mice. Mechanistically, cell-autonomous cGAS and STING promoted the maintenance of stem cell-like CD8+ T cells, in part, by regulating the transcription factor TCF1 expression. Moreover, autocrine cGAS-STING-mediated type I interferon signaling augmented stem cell-like CD8+ T cell differentiation program mainly by restraining Akt activity. In addition, genomic DNA was selectively enriched in the cytosol of mouse CD8+ T cells upon in vitro and in vivo stimulation. STING agonism enhanced the formation of stem-like central memory CD8+ T cells from patients with cancer and potentiated antitumor responses of CAR-T cell therapy in a xenograft model. These findings advance our understanding of inherent cGAS-STING activation in T cells and provide insight into the development of improved T cell therapy by harnessing the cGAS-STING pathway for cancer immunotherapy.

来源:Sci Transl Med,查看原文。版权归原作者所有。

引用

  1. Li W, Lu L, Lu J, et al. cGAS-STING-mediated DNA sensing maintains CD8+ T cell stemness and promotes antitumor T cell therapy. Sci Transl Med. 2020. PMID: 32581136. doi:10.1126/scitranslmed.aay9013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。